Summary
A biopsy report (also called a pathology report) confirms what a tissue sample shows. It names the diagnosis, describes how abnormal the cells look (grade), and may include margins, lymph node findings, and biomarker results that guide treatment. It's written for doctors, so the language can feel cold and confusing, and a single word like "positive" can mean very different things depending on where it appears.
Reading it alongside your oncologist is the safest way to understand it. A biopsy report also isn't the whole story: stage usually needs imaging, and biomarker tests sometimes arrive in a separate report days later.
How to Read Your Biopsy Report: A Plain-Language Guide for Cancer Patients
How to Read Your Biopsy Report: A Plain-Language Guide for Cancer Patients
This page is for informational purposes only and does not replace medical advice. Please consult Dr Aditya Sarin or a qualified oncologist to interpret your own report. Reports vary between laboratories, so the terms below are general guides, not a diagnosis. As of 2026, this reflects current clinical guidance.
Many people get their biopsy report before they can sit with a doctor. You open the PDF, see words like “invasive ductal carcinoma, grade 2” or “margins focally involved,” and your mind races. That’s normal, and it’s why this guide exists. Here’s how to make sense of what’s on the page, without trying to diagnose yourself.
What is a biopsy report?
A biopsy removes a small piece of tissue or a sample of cells for a pathologist to study. A pathologist examines tissue under a microscope and writes the report. The National Cancer Institute describes a pathology report as a medical report that details the characteristics of a tissue specimen taken from a patient.
Types of biopsy
The kind of biopsy you had affects what the report can tell you. Some common procedures include:
- Fine-needle aspiration (FNA): A thin needle draws out fluid and cells
- Core needle biopsy: A larger needle removes a small column of tissue
- Incisional biopsy: Part of a lump or area is removed
- Excisional biopsy: The whole lump or suspicious area is removed
- Endoscopic and bone marrow biopsies: Used for internal organs and for blood cancers
FNA gives the pathologist cells rather than intact tissue, so it can be less informative. A Komen breast biopsy guide notes that FNA can’t fully separate in situ cancer from invasive cancer, which is one reason a core biopsy is often done next.
How long do results take?
Routine results often come within a few days to a week, and special tests such as genetic or molecular testing may take one to three weeks. Timelines in Indian labs vary, so ask when to expect both the main report and any add-on tests. The wait is hard. It doesn’t mean something is wrong.
What’s in a biopsy report?
Formats differ between hospitals and labs, but the American Cancer Society says most reports follow a similar structure.
Patient and specimen details
The top of the report lists your details, the tissue site, the date, and how many samples were taken. Check that your name, age, and the body site are correct. A mix-up here matters.
Gross description
This describes what the pathologist saw with the naked eye: the tissue’s size, colour, and shape. It’s usually the least useful section for patients.
Microscopic description
This is where the real findings sit. The ACS says it usually covers the grade, how the cells are arranged, how far the cancer invades nearby tissue, whether cancer is at the edges of the sample, and lymph node status. Results of extra tests, such as special stains or biomarkers, may appear here or in a separate section.
Final diagnosis
This is the summary line, and the part most patients read first. For cancers, many reports include a structured checklist-style summary (a synoptic report) with tumour size, grade, margins, lymph nodes, and biomarkers. The NCI notes that this is where the cancer type, grade, lymph node status, margin status, and stage are identified.
Key terms in plain language
Benign, suspicious, atypical, malignant
Benign means not cancer. Malignant means cancer. Atypical or suspicious means the cells look abnormal, but the pathologist can’t call it cancer with certainty, so more sampling or surgery may follow. A biopsy doesn’t automatically mean cancer. Many results turn out to be noncancerous.
In situ vs invasive
In situ means abnormal cells are confined to where they started and haven’t grown into surrounding tissue. Invasive means the cells have grown beyond that layer. The distinction changes treatment, which is why it’s worth asking about if your report mentions either.
Grade: How abnormal the cells look
Grade describes how closely tumour cells resemble normal cells. As WebMD explains, grade 1 is low grade (well-differentiated), grade 2 is moderate, and grade 3 is high grade (poorly differentiated), with higher grades generally growing and spreading faster. Different cancers use different grading scales, so a “grade 2” in one cancer isn’t directly comparable to another.
Margins: Was it all removed?
If you had surgery, the report states whether cancer cells reach the edge of the removed tissue. The NCI describes negative (clean) margins as no cancer cells at the edge, suggesting all of the cancer was removed. Positive or involved margins mean cancer cells are at the edge, and your team may recommend more surgery or other treatment. Close margins mean cancer is near, but not at, the edge.
Lymph nodes: Positive or negative
Nodes are called positive if they contain cancer cells and negative if they don’t. The report may list how many nodes were examined and how many were affected. A positive node doesn’t automatically mean the worst, but it feeds into staging and treatment decisions.
Grade is not stage
This trips up a lot of people. Grade is what the cells look like under the microscope. Stage is how large the cancer is and how far it has spread. Staging often uses the TNM system, where T describes the tumour, N describes lymph nodes, and M describes spread to other parts of the body. A pathology report alone may not give a full stage, because staging usually combines the report with scans and other tests.
Biomarker results: ER, PR, HER2, PD-L1, Ki-67
Biomarker tests assess tumour features that guide treatment. For breast cancer, reports typically include hormone receptor (ER and PR) and HER2 status. The Canadian Breast Cancer Network adds that PD-L1 testing helps decide whether some people with triple-negative breast cancer could receive immunotherapy, and that Ki-67 reflects how quickly cells are dividing. Biomarker results may arrive in a separate or later report, so a first report that doesn’t list them isn’t necessarily incomplete.
This ties into treatment choices covered in our guide to cancer treatment options in India.
Common phrases decoded
What you read | In plain language |
Benign | Not cancer |
Malignant / carcinoma | Cancer |
Atypical/suspicious | Abnormal cells, not clearly cancer; more testing may be needed |
In situ | Cancer cells confined to where they began |
Invasive | Cancer cells have grown into nearby tissue |
Well differentiated (grade 1) | Cells look close to normal; usually slower growing |
Poorly differentiated (grade 3) | Cells look very abnormal; usually faster growing |
Margins negative/clear | No cancer at the edge of removed tissue |
Margins positive/involved | Cancer reaches the edge; more treatment may be needed |
Lymph nodes positive | Cancer cells found in a node |
Lymph nodes negative | No cancer cells found in nodes examined |
Addendum | Extra results added after the original report |
Questions to ask your doctor
- What exactly is my diagnosis, in plain words?
- What are the grade and, if available, the stage? If staging isn’t complete, what tests are still needed?
- Were biomarker or molecular tests done? When will the results come?
- (If surgery was done) Are the margins clear, and are the lymph nodes involved?
- Does this report change my treatment options?
- Should the slides or tissue block be reviewed by another pathologist?
When to get a second opinion on your pathology
A cancer diagnosis shapes everything that follows, so it’s reasonable to confirm it, especially if the report is unclear, the diagnosis is rare, or the biopsy was done at a small lab. Hospitals in India routinely review slides from outside labs.
What to send
- The paraffin block, if possible. A block lets the reviewing lab cut new sections and run extra tests, which a finished slide can’t do, according to Acıbadem’s pathology guidance.
- The slides and the original report.
- Relevant scans. Context helps the reviewing pathologist.
Labs release blocks and slides on written request, and it’s an administrative step that can take a little time, so start early. Several centres offer this service.
Keep your tissue blocks and slides safe. They’re part of your medical record and can be needed again years later.
What a biopsy report can’t tell you
- Your full stage: That needs imaging and sometimes more tests.
- How your treatment will go: Grade and biomarkers inform decisions, but they don’t predict outcomes.
- Everything at once: Reports can change. An addendum may add biomarker results or a revised interpretation, so ask whether any tests are still pending.
The takeaway
A biopsy report is the foundation of your treatment plan, and understanding it helps you take part in decisions instead of just receiving them. Read it once for the big picture, write down your questions, and review it with your oncologist rather than looking up each term on your own. If your diagnosis has just come through and you want a clear explanation, book a consultation with Dr Aditya Sarin to get a coordinated starting point.
References
- National Cancer Institute: Pathology Reports
- American Cancer Society: Understanding Your Pathology Report
- American Cancer Society: What’s in a Pathology Report
- American Cancer Society: Breast Cancer Pathology
- WebMD: Understanding Your Cancer Pathology Results
- Komen: Breast Biopsy Guide (via CancerQuest)
- Canadian Breast Cancer Network: Pathology Reports
- Indian Journal of Medical Research: Review of Tissue Diagnosis and Its Role in Cancer Care
- Acıbadem International: Pathology and Second-Opinion Slide Review
Frequently Asked Questions
Does a biopsy always mean I have cancer?
No. A biopsy is done to find out what’s causing a lump or abnormal finding, and many results are benign. It’s the only reliable way to confirm cancer, which is why it’s recommended.
What does “positive” mean on a biopsy report?
It depends on context. For margins, positive means cancer at the edge of the removed tissue. For lymph nodes, it means cancer cells were found. For a biomarker like ER, positive means the tumour has that receptor.
What is the difference between grade and stage?
Grade describes how abnormal the cells look under a microscope. Stage describes how big the cancer is and how far it has spread. They answer different questions.
How long do biopsy results take?
Often, a few days to a week, and special molecular tests can take 1 to 3 weeks. Ask your lab or doctor for a timeline for your specific tests.
Should I get a second opinion on my biopsy?
It’s reasonable, especially if the diagnosis is unclear or rare. A second pathologist reviews your original slides or tissue block, and many cancer centres in India offer this.
Can a pathology report change after it’s issued?
Yes. Additional results, such as biomarker tests, can be added as an addendum, and a report can be amended after further review.
Dr. Aditya Sarin
Consultant, Medical Oncology · Sir Ganga Ram Hospital, New Delhi
MD (General Medicine) · DrNB (Medical Oncology) · ESMO (European) Board Certified
Dr. Aditya Sarin is a medical oncologist who combines precision molecular profiling with evidence-based, compassionate cancer care. Named Young Medical Oncologist of the Year, he treats the full spectrum of solid and blood cancers through a multidisciplinary tumor-board approach at Sir Ganga Ram Hospital.

